世界のバイオマテリアル市場 – 2031 年までの業界動向と予測

バイオマテリアル市場の分析と規模

薬物送達の分野では、生体材料はナノ粒子、マイクロスフィア、ハイドロゲルなどの革新的なシステムのバックボーンとして機能します。これらのプラットフォームは治療薬をカプセル化し、分解から保護し、体内の標的部位への正確な送達を可能にします。通常ナノメートル規模のナノ粒子は、細胞への取り込みを高め、循環時間を延長します。マイクロスフィアは制御された放出速度を提供し、長期間にわたって治療レベルを維持します。調整可能な特性を持つハイドロゲルは、特定の生理学的条件に応じて薬物放出を空間的および時間的に制御します。

世界のバイオマテリアル市場規模は、2023年に1,767.3億米ドルと評価され、2024年から2031年の予測期間中に13.98%のCAGRで成長し、2031年までに5,034.2億米ドルに達すると予測されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

レポートの範囲と市場セグメンテーション       

Market Definition

Biomaterials are substances engineered to interact with biological systems for medical purposes, ranging from implants and prosthetics to drug delivery systems. They are designed to be compatible with living tissues, promoting healing and regeneration while often possessing specific mechanical, chemical, and biological properties. Biomaterials play a crucial role in various medical applications, facilitating advancements in healthcare and improving patient outcomes.

Hair Transplant Market Dynamics

Drivers                                                                                          

• Growing Technological Advancements

Breakthroughs in material science, nanotechnology, and biotechnology continually enhance the properties and functionalities of biomaterials, unlocking new applications and improving existing ones. These advancements enable the development of biomaterials with tailored properties such as biocompatibility, mechanical strength, and controlled degradation, meeting the diverse needs of medical, pharmaceutical, and other industries. Advancements in manufacturing processes, such as additive manufacturing and biofabrication, enable the production of complex biomaterial structures with precise control at the micro and nanoscale, driving the market forward.

• Rising Elderly Population

The growing aging population is more prone to age-related health issues such as osteoarthritis, cardiovascular diseases, and dental problems, necessitating the use of biomaterials in medical implants, prosthetics, and tissue engineering solutions. Biomaterials play a crucial role in restoring function and quality of life for elderly individuals by providing durable and biocompatible replacements for degenerated tissues and organs. The demand for biomaterials is amplified by the desire for active and independent lifestyles among the elderly, driving innovation in materials science and biomedical engineering to meet the unique needs of this demographic.

Opportunities

• Increasing Supportive Government Policies

Policies such as research grants, tax incentives, and regulatory frameworks aimed at promoting innovation in healthcare and biotechnology stimulate investment in biomaterials research and development. Additionally, government initiatives focused on healthcare infrastructure development and public health programs create demand for advanced biomaterials used in medical devices, implants, and regenerative medicine. Supportive policies accelerate the translation of biomaterials research into tangible products and therapies by fostering collaboration between academia, industry, and regulatory bodies that ultimately drives market expansion and improving patient outcomes.

• Increasing Demand for Minimally Invasive Procedures

Patients seek less invasive treatment options through which there's a growing need for biomaterials that enable the development of advanced medical devices and surgical techniques. Biomaterials play a pivotal role in these procedures by providing materials for implants, instruments, and surgical tools that are compatible with the body and promote healing. Moreover, biomaterials facilitate the creation of specialized coatings and drug delivery systems used in minimally invasive interventions, enhancing their efficacy and safety. This trend towards minimally invasive procedures drives innovation in biomaterials, spurring research and development efforts to meet the evolving needs of patients and healthcare providers.

Restraints/Challenges

• High Development Costs

The research and development process for biomaterials involves substantial investment in specialized equipment, materials, and skilled personnel. In addition, conducting preclinical and clinical trials to ensure safety and efficacy further adds to the expense. These high costs can deter smaller companies and startups from entering the market, limiting competition and innovation. Moreover, the lengthy development timeline coupled with uncertain regulatory pathways can prolong the time to market, increasing overall expenses and hindering profitability.

• Growing Competition from Alternative Therapies

Traditional treatment modalities such as pharmaceuticals, surgeries, and non-invasive procedures offer established alternatives to biomaterial-based interventions. Patients or healthcare providers may prefer these alternatives due to factors such as familiarity, perceived efficacy, or cost-effectiveness. Biomaterials face stiff competition in the healthcare landscape, requiring continuous innovation and differentiation to maintain market relevance and capture market share.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In October 2023, Evonik launched VESTAKEEP iC4612 3DF and iC4620 3DF, pioneering carbon-fiber-reinforced PEEK filaments for 3D-printed medical implants. These filaments offer a unique combination of strength, ductility, and adaptability, marking a significant leap in personalized medical treatments and underlining Evonik's dedication to innovation in patient care
• In April 2023, Novo Nordisk forged a strategic collaboration with Aspect Biosystems to develop bioprinted tissue therapeutics targeting obesity and diabetes. This collaboration leverages Aspect Biosystems' expertise in bioprinting biomaterials, aligning with Novo Nordisk's commitment to advancing cutting-edge treatments for metabolic disorders
• In March 2023, Invibio Biomaterial Solutions launched Peek-Optima Am filament, a polyetheretherketone polymer-based material designed for the 3D printing of medical devices. This launch expands Invibio's portfolio of innovative biomaterials, offering enhanced manufacturing capabilities for medical applications and reinforcing its position as a leader in the biomaterials industry
• In January 2023, Zimmer Biomet Holdings, Inc. announced its acquisition plans for Embody, Inc., with an initial investment of USD 155 million, potentially increasing to USD 275 million based on future milestones. This strategic move aims to bolster Zimmer Biomet's sports medicine portfolio, particularly focusing on advanced soft tissue healing solutions, reflecting the company's commitment to expanding its product offerings through strategic acquisitions

Biomaterials Market Scope

The market is segmented on the basis of type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Metallic Biomaterials
  • Stainless Steel
  • Titanium and Titanium Alloys
  • Cobalt-Chrome Alloys
  • Gold
  • Silver
  • Magnesium
• Polymeric Biomaterials
  • Polymethylmethacrylate
  • Polyethylene
  • Polyester
  • Polyvinylchloride
  • Silicone Rubber
  • Nylon
  • Polyetheretherketone
  • Other Polymeric Biomaterials
• Ceramics
  • Calcium Phosphate
  • Zirconia
  • Aluminum Oxide
  • Calcium Sulfate
  • Carbon
  • Glass
• Natural Biomaterials
  • Hyaluronic Acid
  • Collagen
  • Gelatin
  • Fibrin
  • Cellulose
  • Chitin
  • Alginates
  • Silk

Application

• Cardiovascular
  • Catheters
  • Stents
  • Implantable Cardiac Defibrillators
  • Pacemakers
  • Sensors
  • Heart Valves
  • Vascular Grafts
  • Guidewires
  • Others
• Orthopaedic
  • Joint Replacement
  • Knee Replacement
  • Hip Replacement
  • Shoulder Replacement
  • Others
• Ophthalmology
  • Contact Lenses
  • Intraocular Lenses
  • Functional Replacement of Ocular Tissues
  • Synthetic Corneas
  • Others
• Dental
  • Dental Implants
  • Dental Bone Grafts and Substitutes
  • Dental Membranes
  • Tissue Regeneration
• Plastic Surgery
  • Soft-Tissue Fillers
  • Craniofacial Surgery
• Wound Healing
  • Wound Closure Devices
  • Sutures
  • Staples
  • Surgical Hemostats
  • Internal Tissue Sealants
  • Adhesion Barriers
  • Hernia Meshes
• Tissue Engineering
  • Scaffolds for Regenerative Medicine
  • Nanomaterials for Biosensing
  • Tailoring of Inorganic Nanoparticles
• Neurological/Central Nervous System Applications
  • Shunting Systems
  • Cortical Neural Prosthetics
  • Hydrogel Scaffolds for CNS Repair
  • Neural Stem Cell Encapsulation
• Other Applications
  • Drug Delivery Systems
  • Gastrointestinal Applications
  • Bariatric Surgery
  • Urinary Applications

 Biomaterials Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, type, and application, as referenced above.

The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.   

North America is expected to dominate the market is fueled by a combination of favorable government policies supporting research and development initiatives and stringent regulatory frameworks that encourage innovation. Additionally, the region benefits from the presence of numerous major market players, fostering a robust ecosystem for collaboration and investment. This conducive environment has propelled North America to the forefront of biomaterials innovation, driving advancements in medical devices, tissue engineering, and regenerative medicine.

Asia-Pacific is expected to have significant growth due to strategic initiatives undertaken by local stakeholders to bolster their market presence both domestically and internationally. These initiatives encompass various measures such as investment in infrastructure, technological advancements, and fostering partnerships to enhance competitiveness. As a result, the region is expected to experience robust economic expansion, driving growth in diverse sectors and solidifying its position as a key player in the market landscape.

レポートの国別セクションでは、市場の現在および将来の動向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。下流および上流のバリュー チェーン分析、技術動向、ポーターの 5 つの力の分析、ケース スタディなどのデータ ポイントは、各国の市場シナリオを予測するために使用される指標の一部です。また、国別データの予測分析を提供する際には、グローバル ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、国内関税と貿易ルートの影響も考慮されます。

ヘルスケアインフラの成長 導入ベースと新技術の浸透

この市場では、各国の医療設備支出の増加、市場向け各種製品のインストールベース、ライフライン曲線を使用した技術の影響、医療規制シナリオの変化と市場への影響など、詳細な市場分析も提供しています。データは、2016年から2021年までの履歴期間について利用可能です。

競争環境とバイオマテリアル市場分析

市場競争環境では、競合他社の詳細が提供されます。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供される上記のデータ ポイントは、市場に関連する会社の焦点にのみ関連しています。

市場で活動している主要企業は次のとおりです。

• ジョンソン・エンド・ジョンソン（米国）
• ストライカー（米国）
• クアーズテック社（米国）
• ジマーバイオメット（米国）
• コルビオノラーゲンマトリックス社（米国）
• CRSホールディングスLLC（米国）
• バークレー先端バイオマテリアルズ（米国）
• コバロンテクノロジーズ社（カナダ）
• メドトロニック（アイルランド）
• BASF SE（ドイツ）
• エボニック インダストリーズ AG (ドイツ)
• インビビオ株式会社（英国）

SKU-59542